Capital International Investors 13D and 13G filings for Karuna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 12:25 pm Sale | 2024-02-12 | 13G | Karuna Therapeutics, Inc. KRTX | Capital International Investors | 448,866 1.200% | -3,865,518 (-89.60%) | Filing |
| 2024-02-09 5:19 pm Purchase | 2024-02-07 | 13G | Karuna Therapeutics, Inc. KRTX | Capital International Investors | 4,314,384 11.400% | 475,644 (+12.39%) | Filing |
| 2023-06-09 3:48 pm Purchase | 2023-06-12 | 13G | Karuna Therapeutics, Inc. KRTX | Capital International Investors | 3,838,740 10.300% | 3,838,740 (New Position) | Filing |